[1]Cheung N, Mitchell P, Wong T Y. Diabetic retinopathy[J]. Lancet, 2010, 376(9735): 124-136.
[2]American Diabetes Association. 10. Microvascular complications and foot care: standards of medical care in diabetes-2018[J]. Diabetes Care, 2018, 41(Suppl 1): S105-S118.
[3]Fong D S, Aiello L, Gardner T W, et al. Retinopathy in diabetes[J]. Diabetes Care, 2004, 27 (Suppl 1): S84-S87.
[4]Ting D S W, Cheung G C M, Wong T Y. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review[J]. Clin Exp Ophthalmol, 2016, 44(4): 260-277.
[5]Lachin J M, Genuth S, Nathan D M, et al. Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial-revisited[J]. Diabetes, 2008, 57(4): 995-1001.
[6]徐嫚鸿, 李筱荣. 蛋白质组学在糖尿病视网膜病变炎性生物标志物研究中的应用[J]. 中华实验眼科杂志, 2022, 40(9): 869-873.
[7]Kaštelan S, Oreškovic′ I,Bišc′an F, et al. Inflammatory and angiogenic biomarkers in diabetic retinopathy[J]. Biochem Med (Zagreb), 2020, 30(3): 030502.
[8]Youngblood H, Robinson R, Sharma A, et al. Proteomic biomarkers of retinal inflammation in diabetic retinopathy[J]. Int J Mol Sci, 2019, 20(19): 4755.
[9]肖静, 张晓敏, 李筱荣. 糖尿病视网膜病变的蛋白质组学研究进展[J]. 中华眼底病杂志, 2018, 34(4): 407-411.
[10]Angi M, Kalirai H, Coupland S E, et al. Proteomic analyses of the vitreous humour[J]. Mediators Inflamm, 2012, 2012: 148039.
[11]Loukovaara S, Nurkkala H, Tamene F, et al. Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients[J]. J Proteome Res, 2015, 14(12): 5131-5143.
[12]刘尚清, 张艳艳, 羊惠君, 等. 早期糖尿病大鼠视网膜蛋白质表达变化的初步研究[J]. 眼科研究, 2007, 25(3): 186-189.
[13]Wan T T, Li X F, Sun Y M, et al. Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy[J]. Biomed Pharmacother, 2015, 74: 145-147.
[14]Burgos R, Mateo C, Cantón A, et al. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study[J]. Diabetes Care, 2000, 23(1): 80-83.
[15]Fukuda R, Hirota K, Fan F, et al. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells[J]. J Biol Chem, 2002, 277(41): 38205-38211.
[16]Wang W, Lo A C Y. Diabetic retinopathy: pathophysiology and treatments[J]. Int J Mol Sci, 2018, 19(6): 1816.
[17]DeBosch B J, Baur E, Deo B K, et al. Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation[J]. J Neurochem, 2001, 77(4): 1157-1167.
[18]赵世民, 林志光. 肾素-血管紧张素系统与现代医学[M]. 济南: 山东大学出版社, 1995.
[19]Huang K K, Liang Y L, Wang K, et al. Elevated ACE levels indicate diabetic nephropathy progression or companied retina impaired[J]. Front Clin Diabetes Healthc, 2022, 3: 831128.
[20]Letizia C, Repossi P, Sellini M, et al. Serum angiotensin converting enzyme in diabetic retinopathy[J]. Int J Tissue React, 1992, 14: 299-305.
[21]郭志新, 许笑梅, 司兆敏. 血浆内皮素和血清血管紧张素转换酶与糖尿病视网膜病变的关系[J]. 中华眼底病杂志, 1996(3): 39-41.
[22]Otani A, Takagi H, Oh H, et al. Angiotensin Ⅱ-stimulated vascular endothelial growth factor expression in bovine retinal pericytes[J]. Invest Ophthalmol Vis Sci, 2000, 41(5): 1192-1199.
[23]Wang X, Bai Y P, Hong D, et al. Ang Ⅱ induces capillary formation from endothelial cells via the AT1R-dependent inositol requiring enzyme 1 pathway[J]. Biochem Biophys Res Commun, 2013, 434(3): 552-558.
[24]Ola M S, Alhomida A S, Ferrario C M, et al. Role of tissue renin-angiotensin system and the chymase/angiotensin-(1-12) axis in the pathogenesis of diabetic retinopathy[J]. Curr Med Chem, 2017, 24(28): 3104-3114.
[25]Wells A L, Lin A W, Chen L Q, et al. Myosin Ⅵ is an actin-based motor that moves backwards[J]. Nature, 1999, 401(6752): 505-508.
[26]Brown M E, Bridgman P C. Myosin function in nervous and sensory systems[J]. J Neurobiol, 2004, 58(1): 118-130.
[27]Samuels I S, Bell B A, Sturgill-Short G, et al. Myosin 6 is required for iris development and normal function of the outer retina[J]. Invest Ophthalmol Vis Sci, 2013, 54(12): 7223-7233.
|